Katsutoshi Miyosawa

发表

Mass spectrometry meets the challenge of understanding the complexity of the lipoproteome: recent findings regarding proteins involved in dyslipidemia and cardiovascular disease

Sasha A. Singh, M. Aikawa, K. Miyosawa, 2015, Expert review of proteomics.

The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation

K. Shimada, H. Daida, T. Minamino, 2021, Scientific Reports.

Reduced Number of Platelets During Intra-Aortic Balloon Pumping Counterpulsation Predicts Higher Cardiovascular Mortality After Device Removal in Association with Systemic Inflammation.

H. Daida, S. Suwa, H. Iwata, 2020, International heart journal.

Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention

T. Kasai, T. Dohi, S. Okazaki, 2024, Cardiovascular diabetology.

Low expression of cell-surface thromboxane A2 receptor beta-isoform through the negative regulation of its membrane traffic by proteasomes.

N. Nakahata, S. Ohkubo, T. Yanagisawa, 2007, Prostaglandins & other lipid mediators.

Physiological significance of thromboxane A(2) receptor dimerization.

N. Nakahata, S. Ohkubo, Masako Sasaki, 2006, Journal of pharmacological sciences.

Different pathways for activation of extracellular signal-regulated kinase through thromboxane A2 receptor isoforms.

N. Nakahata, S. Ohkubo, Masako Sasaki, 2006, Biological & pharmaceutical bulletin.

Enhanced monocyte migratory activity in the pathogenesis of structural remodeling in atrial fibrillation

H. Daida, T. Minamino, H. Iwata, 2020, PloS one.

Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study

H. Daida, Y. Nishida, H. Iwata, 2020, Cardiovascular Diabetology.

New CETP inhibitor K-312 reduces PCSK9 expression: a potential effect on LDL cholesterol metabolism.

Sasha A. Singh, M. Aikawa, H. Yamazaki, 2015, American journal of physiology. Endocrinology and metabolism.

Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis

T. Minamino, T. Kasai, T. Dohi, 2022, Scientific Reports.

Dipeptidyl Peptidase-4 Inhibitors Reduced Long-term Cardiovascular Risk in Japanese Diabetic Patients After Percutaneous Coronary Intervention via Insulin-like Growth Factor-1 Axis: A 10-year Follow-up Study

T. Minamino, T. Kasai, T. Dohi, 2021 .